论文部分内容阅读
目的:观察降纤酶治疗高粘血症的疗效及安全性。方法:将94例高粘血症患者随机分为治疗组与对照组各47例,治疗组用降纤酶治疗,对照组用传统方法治疗。结果:两组Fib、Q值和Hct与治疗前后比较有显著性差异。结论:降纤酶是治疗高粘血症的一种安全有效的药物。
Objective: To observe the efficacy and safety of defibrase in the treatment of hyperviscosity. Methods: 94 patients with hyperviscosity were randomly divided into treatment group and control group, 47 cases in each group. The treatment group was treated with defibrase and the control group was treated by traditional method. Results: There were significant differences in Fib, Q value and Hct between the two groups before and after treatment. Conclusion: Defibrase is a safe and effective drug for the treatment of hyperviscosity.